Skip to main content

Table 2 Surgical and medical treatments used for G-NENs

From: Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience

Variables Mean ± SD (Numbers/Percentage)
Surgical approaches
 Endoscopic resection 25/135 (18.5 %)
 Open/Laparoscopic surgery 110/135 (81.5 %)
Types of gastrectomy*
 Proximal gastrectomy 38/110 (34.5 %)
 Distal gastrectomy 39/110 (35.5 %)
 Total gastrectomy 31/110 (28.2 %)
 Wedge resection 2/110 (1.8)
Multivisceral resection#
 Gastrectomy + splenectomy 2/110 (1.8 %)
 Gastrectomy + partial hepatectomy 1/110 (0.9 %)
Surgical margins
 R0 114/135 (84.4 %)
 R1/R2 21/135 (15.6 %)
Surgical complications
 Abdominal infection 2/135 (1.5 %)
 Intestinal obstruction 3/135 (2.2 %)
 Alimentary tract bleeding 5/135 (3.7 %)
 Pulmonary infection 4/135 (3.0 %)
 Perioperative death 0/135 (0.0 %)
Postoperative medical treatments
 Cytotoxic chemotherapy 20 (14.8 %)
 Somatostatin analogs 10 (7.4 %)
  1. G-NENs gastric neuroendocrine neoplasms; *#including the patients who underwent Open/Laparoscopic surgery